Anupam Rasayan India Ltd , a leading specialty chemicals company, has reported a strong financial performance for the second quarter of the fiscal year 2025-26. The company's results showcase significant growth in revenue and profitability, despite a contraction in margins.

Revenue Soars

For the quarter ended September 30, 2025, Anupam Rasayan reported a consolidated revenue of ₹7,313.98 crore, marking a substantial increase of 148.8% compared to ₹2,939.62 crore in the same quarter of the previous year. This impressive top-line growth underscores the company's expanding market presence and strong demand for its specialty chemical products.

Profitability Surge

The company's bottom line saw a significant improvement:

• Net profit for Q2 FY2025-26 stood at ₹571.52 crore, up by 86.6% from ₹306.23 crore in Q2 FY2024-25.
• On a half-yearly basis, the net profit reached ₹1,056.10 crore, showing a remarkable growth of 146.6% compared to ₹428.34 crore in the corresponding period of the previous year.

EBITDA Performance

Anupam Rasayan's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) for the quarter increased to ₹1,358.89 crore, up from ₹804.05 crore in the same quarter last year, representing a growth of 68.9%.

Margin Pressure

Despite the strong revenue and profit growth, the company experienced some pressure on its margins:

• EBITDA margin for Q2 FY2025-26 contracted to 18.54% from 27.35% in Q2 FY2024-25.
• This margin contraction suggests that while the company has significantly expanded its operations, it may be facing some cost pressures or changes in product mix affecting overall profitability ratios.

Financial Position

As of September 30, 2025, Anupam Rasayan's balance sheet reflects a solid financial position:

• Total assets stood at ₹56,498.46 crore, up from ₹52,688.84 crore as of March 31, 2025.
• The company's equity base expanded to ₹31,972.88 crore, compared to ₹28,503.13 crore at the end of the previous fiscal year.

Capital Allocation

During the quarter, Anupam Rasayan made strategic moves to strengthen its capital structure:

• The company allotted 39,14,886 fully paid-up equity shares at an issue price of ₹945.11 per share through a preferential allotment.
• This move raised approximately ₹3,700 crore, of which ₹2,768.98 crore has been utilized for loan repayment and general corporate purposes.

Looking Ahead

As Anupam Rasayan continues to expand its operations and capitalize on the growing demand for specialty chemicals, managing costs and improving operational efficiency will be key focus areas to enhance profitability margins in the coming quarters.

The company's robust financial performance, coupled with its strategic capital raising, positions it well for future growth in the dynamic specialty chemicals sector.

Anupam Rasayan India Limited , a leading custom synthesis and specialty chemical player, has announced significant expansions in its long-term contracts and reported robust financial results for the first quarter of fiscal year 2026.

Contract Expansions and Sustainable Growth

The company has successfully expanded its long-term contracts with global leaders in the agrochemical and specialty chemical sectors. This strategic move aligns with Anupam Rasayan's commitment to sustainable growth and strengthening its position in the global market.

As part of its growth strategy, the company is incorporating value-added molecules into its operations. This initiative is expected to enhance its product portfolio and cater to the evolving needs of its global clientele.

Anupam Rasayan is also making substantial investments in eco-friendly processes, underscoring its dedication to sustainable practices in the chemical industry. These investments are likely to improve the company's environmental footprint while meeting the increasing demand for environmentally responsible chemical solutions.

Strong Financial Performance in Q1 FY26

The company's financial results for the quarter ended June 30, 2025, reflect significant growth:

• Consolidated total revenue stood at ₹4,907.00 million, marking an impressive year-on-year growth of 89%.
• EBITDA (including other income) reached ₹1,292.00 million, up by 118% compared to the same quarter last year.
• Profit After Tax (PAT) surged to ₹485.00 million, representing a substantial increase of 297% year-on-year.

Key Financial Highlights

The EBITDA margin for Q1 FY26 stood at an impressive 26%, indicating strong operational efficiency.

Management Commentary

Mr. Anand Desai, Managing Director of Anupam Rasayan, commented on the performance: "We strongly believe that the sectoral trends are in our favor, and we are witnessing a clear resurgence in growth. Our pharma and polymer businesses are performing well, coupled with recovery in the Agrochemical segment. The USA and Japan markets have shown encouraging trends for Anupam Rasayan."

He further added, "During Q1 FY26, total exports accounted for 58% of the total revenue from operations. With the two new agreements signed with Japanese and US-based multinational companies, our order book now stands at ₹14,646.00 crore, reflecting the strong growth momentum in our business."

Business Expansion and Future Outlook

Anupam Rasayan has added one new product in Q1 FY26, taking its total product count to 80. The company's diverse product portfolio caters to various sectors, including agrochemicals, personal care, and pharmaceuticals.

The company's order book of ₹14,646.00 crore demonstrates strong future growth potential and reflects the confidence of global clients in Anupam Rasayan's capabilities.

As Anupam Rasayan continues to expand its long-term contracts, invest in eco-friendly processes, and deliver strong financial results, it is well-positioned to capitalize on the growing demand for specialty chemicals in both domestic and international markets.